We are live on !
Find out more
Brandywine Managers Portfolio holdings
AUM
$202M
Turnover
13.04%
1-Year Est. Return
16.99%
This Fund
S&P 500
This Quarter Est. Return
+1.32%
1 Year Est. Return
+16.99%
3 Year Est. Return
+96.29%
5 Year Est. Return
+26.97%
10 Year Est. Return
+345.77%
AUM
$93M
AUM Growth
-$1.52M
(-1.6%)
Cap. Flow
-$809K
Cap. Flow % of AUM
Cap. Flow %
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
83.21%
Holding
38
New
2
Increased
11
Reduced
1
Closed
3
Avg Time Held
3.6
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viking Therapeutics
VKTX
|
+$474K |
| 2 |
CrowdStrike
CRWD
|
+$350K |
| 3 |
Snowflake
SNOW
|
+$300K |
| 4 |
Samsara
IOT
|
+$300K |
| 5 |
Beam Therapeutics
BEAM
|
+$292K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.68M |
| 2 |
Campbell Soup
CPB
|
+$1.09M |
| 3 |
Morphic Holding, Inc. Common Stock
MORF
|
+$487K |
| 4 |
Fulcrum Therapeutics
FULC
|
+$162K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.96% |
| 2 | Technology | 41.91% |
| 3 | Healthcare | 11.99% |
| 4 | Financials | 0.95% |
| 5 | Consumer Discretionary | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
iShares MSCI ACWI ETF
ACWI
$32.2B
| $41.8M | 44.96% |
349,815
| – | – |
2023 Q1
6 quarters
|
|
2
UiPath
PATH
$6.95B
| $12.8M | 13.76% |
1,000,196
| – | – |
2021 Q2
13 quarters
|
|
|
3
CrowdStrike
CRWD
$248B
| $9.2M | 9.89% |
131,256
+4,932
| +4% | +$350K |
2019 Q2
21 quarters
|
|
|
4
NVIDIA
NVDA
$4.88T
| $2.6M | 2.79% |
21,390
-14,250
| -40% | -$1.68M |
2020 Q1
18 quarters
|
|
5
Natera
NTRA
$54.6B
| $2.33M | 2.5% |
18,338
+894
| +5% | +$103K |
2017 Q3
28 quarters
|
|
6
Uber
UBER
$136B
| $2.21M | 2.37% |
29,354
| – | – |
2023 Q1
6 quarters
|
|
7
Salesforce
CRM
$186B
| $1.89M | 2.03% |
6,913
| – | – |
2020 Q3
16 quarters
|
|
8
Intuitive Surgical
ISRG
$154B
| $1.64M | 1.76% |
3,333
| – | – |
2017 Q3
28 quarters
|
|
|
9
Samsara
IOT
$24.5B
| $1.49M | 1.6% |
30,970
+7,392
| +31% | +$300K |
2021 Q4
11 quarters
|
|
10
Zscaler
ZS
$36.5B
| $1.43M | 1.54% |
8,359
+1,435
| +21% | +$262K |
2018 Q4
23 quarters
|
|
11
Advanced Micro Devices
AMD
$762B
| $1.3M | 1.39% |
7,898
+599
| +8% | +$91K |
2022 Q1
10 quarters
|
|
12
Alnylam Pharmaceuticals
ALNY
$21.2B
| $1.2M | 1.29% |
4,348
| – | – |
2018 Q4
23 quarters
|
|
13
Datadog
DDOG
$77.6B
| $1.16M | 1.25% |
10,100
+878
| +10% | +$103K |
2019 Q3
20 quarters
|
|
14
Twist Bioscience
TWST
$8.56B
| $947K | 1.02% |
20,970
| – | – |
2018 Q4
23 quarters
|
|
15
Okta
OKTA
$32.3B
| $943K | 1.01% |
12,687
| – | – |
2017 Q3
28 quarters
|
|
16
Mastercard
MA
$573B
| $881K | 0.95% |
1,785
| – | – |
2022 Q2
9 quarters
|
|
17
Veeva Systems
VEEV
$49.7B
| $822K | 0.88% |
3,919
| – | – |
2017 Q2
29 quarters
|
|
18
Cloudflare
NET
$94.4B
| $801K | 0.86% |
9,906
| – | – |
2024 Q2
1 quarter
|
|
19
ServiceNow
NOW
$110B
| $799K | 0.86% |
4,465
| – | – |
2016 Q4
31 quarters
|
|
20
MongoDB
MDB
$26.6B
| $773K | 0.83% |
2,859
| – | – |
2024 Q2
1 quarter
|
|
21
Moderna
MRNA
$88.2B
| $636K | 0.68% |
9,510
| – | – |
2018 Q4
23 quarters
|
|
22
Eli Lilly
LLY
$1.26T
| $618K | 0.66% |
697
+109
| +19% | +$98K |
2024 Q2
1 quarter
|
|
|
23
Snowflake
SNOW
$103B
| $573K | 0.62% |
4,988
+2,439
| +96% | +$300K |
2022 Q2
9 quarters
|
|
24
PagerDuty
PD
$1.31B
| $566K | 0.61% |
30,517
| – | – |
2019 Q2
21 quarters
|
|
|
25
Viking Therapeutics
VKTX
$3.42B
| $512K | 0.55% |
+8,082
| New | +$474K |
2024 Q3
0 quarters
|
|
Similar funds
OPL
LAMC
Brandywine Managers's Q3 2024 Portfolio in Review
As of Q3 2024, Brandywine Managers held 38 positions worth $93M, down 1.6% from $94.5M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Brandywine Managers's Q3 2024 filing shows 2 new, 11 increased, 1 reduced and 3 closed positions. Its largest new stake was Viking Therapeutics: 8,082 shares worth $512K. The largest sale was NVIDIA, an estimated $1.68M.
By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, up from 42% a quarter earlier, followed by Technology and Healthcare.
- Brandywine Managers's largest Q3 2024 buy was Viking Therapeutics: 8,082 shares worth $512K.
- Brandywine Managers added most to CrowdStrike in Q3 2024, an estimated $350K increase.
- Brandywine Managers's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $1.68M.
- Brandywine Managers fully exited Campbell Soup in Q3 2024, selling an estimated $1.09M.
- Brandywine Managers's ten largest holdings make up 83% of its $93M portfolio in Q3 2024.
- Brandywine Managers opened 2 new positions and closed 3 in Q3 2024.
- Brandywine Managers's portfolio value fell 1.6% quarter-over-quarter to $93M.
Based on Brandywine Managers's 13F filing for Q3 2024, filed 14 Nov 2024.